NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods

Maria Lorna A. De Leoz, David L. Duewer, Adam Fung, Lily Liu, Hoi Kei Yau, Oscar Potter, Gregory O. Staples, Kenichiro Furuki, Ruth Frenkel, Yunli Hu, Zoran Sosic, Peiqing Zhang, Friedrich Altmann, Clemens Gru Nwald-Grube, Chun Shao, Joseph Zaia, Waltraud Evers, Stuart Pengelley, Detlev Suckau, Anja WiechmannAnja Resemann, Wolfgang Jabs, Alain Beck, John W. Froehlich, Chuncui Huang, Yan Li, Yaming Liu, Shiwei Sun, Yaojun Wang, Youngsuk Seo, Hyun Joo An, Niels Christian Reichardt, Juan Echevarria Ruiz, Stephanie Archer-Hartmann, Parastoo Azadi, Len Bell, Zsuzsanna Lakos, Yanming An, John F. Cipollo, Maja Pucic-Bakovic, Jerko Štambuk, Gordan Lauc, Xu Li, Peng George Wang, Andreas Bock, René Hennig, Erdmann Rapp, Marybeth Creskey, Terry D. Cyr, Miyako Nakano, Taiki Sugiyama, Pui King Amy Leung, Paweł Link-Lenczowski, Jolanta Jaworek, Shuang Yang, Hui Zhang, Tim Kelly, Song Klapoetke, Rui Cao, Jin Young Kim, Hyun Kyoung Lee, Ju Yeon Lee, Jong Shin Yoo, Sa Rang Kim, Soo Kyung Suh, Noortje de Haan, David Falck, Guinevere S.M. Lageveen-Kammeijer, Manfred Wuhrer, Robert J. Emery, Radoslaw P. Kozak, Li Phing Liew, Louise Royle, Paulina A. Urbanowicz, Nicolle H. Packer, Xiaomin Song, Arun Everest-Dass, Erika Lattová, Samanta Cajic, Kathirvel Alagesan, Daniel Kolarich, Toyin Kasali, Viv Lindo, Yuetian Chen, Kudrat Goswami, Brian Gau, Ravi Amunugama, Richard Jones, Corné J.M. Stroop, Koichi Kato, Hirokazu Yagi, Sachiko Kondo, C. T. Yuen, Akira Harazono, Xiaofeng Shi, Paula E. Magnelli, Brian T. Kasper, Lara Mahal, David J. Harvey, Roisin O'Flaherty, Pauline M. Rudd, Radka Saldova, Elizabeth S. Hecht, David C. Muddiman, Jichao Kang, Prachi Bhoskar, Daniele Menard, Andrew Saati, Christine Merle, Steven Mast, Sam Tep, Jennie Truong, Takashi Nishikaze, Sadanori Sekiya, Aaron Shafer, Sohei Funaoka, Masaaki Toyoda, Peter de Vreugd, Cassie Caron, Pralima Pradhan, Niclas Chiang Tan, Yehia Mechref, Sachin Patil, Jeffrey S. Rohrer, Ranjan Chakrabarti, Disha Dadke, Mohammedazam Lahori, Chunxia Zou, Christopher Cairo, Béla Reiz, Randy M. Whittal, Carlito B. Lebrilla, Lauren Wu, Andras Guttman, Marton Szigeti, Benjamin G. Kremkow, Kelvin H. Lee, Carina Sihlbom, Barbara Adamczyk, Chunsheng Jin, Niclas G. Karlsson, Jessica Örnros, Göran Larson, Jonas Nilsson, Bernd Meyer, Alena Wiegandt, Emy Komatsu, Helene Perreault, Edward D. Bodnar, Nassur Said, Yannis Nicolas Francois, Emmanuelle Leize-Wagner, Sandra Maier, Anne Zeck, Albert J.R. Heck, Yang Yang, Rob Haselberg, Ying Qing Yu, William Alley, Joseph W. Leone, Hua Yuan, Stephen E. Stein

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Glycosylation is a topic of intense current interest in the development of biopharmaceuticals because it is related to drug safety and efficacy. This work describes results of an interlaboratory study on the glycosylation of the Primary Sample (PS) of NISTmAb, a monoclonal antibody reference material. Seventy-six laboratories from industry, university, research, government, and hospital sectors in Europe, North America, Asia, and Australia submitted a total of 103 reports on glycan distributions. The principal objective of this study was to report and compare results for the full range of analytical methods presently used in the glycosylation analysis of mAbs. Therefore, participation was unrestricted, with laboratories choosing their own measurement techniques. Protein glycosylation was determined in various ways, including at the level of intact mAb, protein fragments, glycopeptides, or released glycans, using a wide variety of methods for derivatization, separation, identification, and quantification. Consequently, the diversity of results was enormous, with the number of glycan compositions identified by each laboratory ranging from 4 to 48. In total, one hundred sixteen glycan compositions were reported, of which 57 compositions could be assigned consensus abundance values. These consensus medians provide community-derived values for NISTmAb PS. Agreement with the consensus medians did not depend on the specific method or laboratory type. The study provides a view of the current state-of-the-art for biologic glycosylation measurement and suggests a clear need for harmonization of glycosylation analysis methods.

Original languageEnglish
Pages (from-to)11-30
Number of pages20
JournalMCP : Molecular & cellular proteomics
Volume19
Issue number1
Early online date7 Oct 2019
DOIs
Publication statusPublished - 1 Jan 2020

Funding

This work was supported by: 1. Science Foundation Ireland Starting Investigator Research under Grant 13/SIRG/2164 to R.S.; 2. Swedish Research Council under Grant 8266 to G.L. and J.N.; 3. Alberta Glycomics Centre to C.C.; 4. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under Grant K01- DK101632 to J.W.F.; 5. Australian Research Council Centre of Excellence for Nanoscale BioPhotonics (CNBP) under Grant CE1401000003 to N.H.P. and A.E.-D.; 6. European Union (EU) FP7 program HighGlycan under Grant 278535 to R.O.F. and P.M.R.; 7. National Institutes of Health (NIH) Research Resource for Biomedical Glycomics under Grant P41GM10349010 and Grant 1S10OD018530 to P.A.; 8. Austrian Research Promotion Agency Laura Bassi Center of Expertise under Grant 822757 to C.G.-G.; 9. National Natural Science Foundation of China under Grant 31600650, 31671369, and 31770775D to D.B., S.S., C.H. and Y.L.; 10. Deutsche Forschungs- gemeinschaft (DFG, German Research Foundation) "The concert of dolichol-based glycosylation: from molecules to disease models" under Grant FOR2509 to E.R.; 11. European Union (EC) "IMforFuture" under Grant 721815 to E.R.; 12. German Federal Ministry of Education and Research (BMBF) "Die Golgi Glykan Fabrik 2.0" under Grant 031A557 to S.C. and E.R.; 13. Health Canada, Government of Canada to T.D.C. and M.C.; 14. European Union FP7 GastricGlycoExplorer ITN under Grant 316929 and the Swedish Research Council under Grant 621-2013-5895 to N.G.K.; 15. National Research Council of Science and Technology Creative Allied Project (CAP) under Grant NTM2371511 to J.S.Y.; 16. Hungarian Government project under Grant NKFIH-K 116263 and BIONANO GINOP-2.3.2- 15-2016-00017 to A.G.; and 17. National Research Foundation of Korea under Grant NRF-2013M3A9B6075933 to H.J.A. * This work was supported by: 1. Science Foundation Ireland Starting Investigator Research under Grant 13/SIRG/2164 to R.S.; 2. Swedish Research Council under Grant 8266 to G.L. and J.N.; 3. Alberta Glycomics Centre to C.C.; 4. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under Grant K01-DK101632 to J.W.F.; 5. Australian Research Council Centre of Excellence for Nanoscale BioPhotonics (CNBP) under Grant CE1401000003 to N.H.P. and A.E.-D.; 6. European Union (EU) FP7 program HighGlycan under Grant 278535 to R.O.F. and P.M.R.; 7. National Institutes of Health (NIH) Research Resource for Biomedical Glycomics under Grant P41GM10349010 and Grant 1S10OD018530 to P.A.; 8. Austrian Research Promotion Agency Laura Bassi Center of Expertise under Grant 822757 to C.G.-G.; 9. National Natural Science Foundation of China under Grant 31600650, 31671369, and 31770775D to D.B., S.S., C.H. and Y.L.; 10. Deutsche Forschungs- gemeinschaft (DFG, German Research Foundation) “The concert of dolichol-based glycosylation: from molecules to disease models” under Grant FOR2509 to E.R.; 11. European Union (EC) “IMforFuture” under Grant 721815 to E.R.; 12. German Federal Ministry of Education and Research (BMBF) “Die Golgi Glykan Fabrik 2.0” under Grant 031A557 to S.C. and E.R.; 13. Health Canada, Government of Canada to T.D.C. and M.C.; 14. European Union FP7 GastricGlycoExplorer ITN under Grant 316929 and the Swedish Research Council under Grant 621–2013-5895 to N.G.K.; 15. National Research Council of Science and Technology Creative Allied Project (CAP) under Grant NTM2371511 to J.S.Y.; 16. Hungarian Government project under Grant NKFIH-K 116263 and BIONANO GINOP-2.3.2-15–2016-00017 to A.G.; and 17. National Research Foundation of Korea under Grant NRF-2013M3A9B6075933 to H.J.A. □S This article contains supplemental Figures, Tables, and Discussion.

FundersFunder number
FP7 GastricGlycoExplorer621–2013-5895
National Research Council of Science and Technology Creative Allied Project
National Institutes of Health822757, P41GM10349010
NIH Office of the DirectorS10OD018530
National Institute of Diabetes and Digestive and Kidney DiseasesK01- DK101632
California Department of Fish and Game
Canadian Association of PalynologistsNTM2371511
Seventh Framework Programme721815, 278535, 316929
ARC Centre for Nanoscale BioPhotonicsCE1401000003
Health Canada
Government of Canada
European Commission
Deutsche ForschungsgemeinschaftFOR2509
National Natural Science Foundation of China31671369, 31600650, 31770775D
Bundesministerium für Bildung und Forschung031A557
Alberta Glycomics Centre
National Research Foundation of KoreaNRF-2013M3A9B6075933
Vetenskapsrådet8266

    Keywords

    • fluorescence
    • glycan
    • Glycomics
    • glycopeptide
    • glycoproteins
    • glycosylation
    • interlaboratory study
    • mass spectrometry
    • NISTmAb
    • reference antibody

    Fingerprint

    Dive into the research topics of 'NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods'. Together they form a unique fingerprint.

    Cite this